Background: Follicular lymphoma (FL) is the most common indolent lymphoma and the 2nd
most common non-Hodgkin lymphoma, accounting for 10%–20% of all lymphomas in the …

Background Since the 1990s and since the development of humanised monoclonal
antibodies in 1998, the treatment of non‐Hodgkin lymphoma has undergone profound …

Follicular lymphoma (FL) is one of the most common indolent non-Hodgkin lymphoma (NHL)
subtype in Western countries. Although understanding of the epidemiology of NHL subtypes …

Purpose Despite several new treatment options, single-and multi-institution analyses have
not clarified whether survival patterns in follicular lymphoma (FL) patients have changed in …

Purpose Optimal therapy of follicular lymphoma (FL) is not defined. We analyzed a large
prospective cohort study to identify current demographics and patterns of care of FL in the …

Background Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma
(NHL) in Western countries. However, it is relatively rare in Asia. This study examined …

Available epidemiological reports on follicular lymphoma (FL) often highlight a significant
discrepancy between its high and low incidence rates in Western and Eastern Europe …

Clinical features and outcomes of FL patients in Chinese population are limited, thus
promoting us to perform this analysis on a large cohort of 1845 patients with FL enrolled …

Purpose A recent report suggested improvements in survival after follicular lymphoma (FL),
but not for all racial/ethnic groups. To better understand the reasons for these FL survival …

Background The incidence of follicular lymphoma (FL) varies according to geographic
location. It is the second most common non-Hodgkin lymphoma in Western countries but has …